apl. Prof. Dr. Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease (2025) Topping J, Chang L, Nadat F, Poulter JA, Ibbotson A, Lara-Reyna S, Watson CM, et al. Journal article GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets (2025) Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, et al. Journal article Patients with Adult-Onset Still’s Disease in Germany: A Retrospective Analysis of Clinical Characteristics and Treatment Practices Ahead of the Release of the German Recommendations (2025) Schönau V, Wendel S, Tascilar K, Henes J, Feist E, Baerlecken NT, Popp F, et al. Journal article Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study (2025) Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, Angeli MR, et al. Journal article From whole-brain metrics to circuitspecific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis – Authors' reply (2025) Heß A, Tascilar K, Schett G, Rech J Journal article Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study (2025) Heß A, Tascilar K, Schenker H, Konerth L, Schönau V, Sergeeva M, Kreitz S, et al. Journal article First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study (2025) Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry (2025) Oommen PT, Kallinich T, Rech J, Blank N, Weber-Arden J, Kuemmerle-Deschner JB Journal article, Original article Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome (2024) Reuner M, Krehbiel J, Rech J, Greiner B, Schäfer I, Herold R, Morawa E, Erim Y Journal article Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey (2024) Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, et al. Journal article